Angiogenesis inhibitors.

被引：13
|
作者：
Tennant T.R. [1 ]
Rinker-Schaeffer C.W. [1 ]
Stadler W.M. [1 ]
机构：
[1] Section of Hematology/Oncology, University of Chicago, 5841 South Maryland, Chicago, 60637, IL
来源：
Current Oncology Reports | 2000年 / 2卷 / 1期
关键词：
Vascular Endothelial Growth Factor; Thalidomide; Angiogenesis Inhibitor; Clinical Trial Design; SU5416;
D O I：
10.1007/s11912-000-0005-0
中图分类号：
学科分类号：
摘要：
Angiogenesis inhibitors target the neovascular development that is hypothesized to underlie tumor growth. The inhibitors that are undergoing the clinical testing phase can be divided into five categories based on their target activity: 1) drugs that block matrix breakdown; 2) drugs that inhibit endothelial cells directly; 3) drugs that block angiogenesis activators; 4) drugs that inhibit endothelial cell integrins or survival signaling; and 5) drugs with a currently unknown mechanism of action. The properties of these drugs and some specific agents in each class are reviewed in this article. Because growth inhibition rather than tumor shrinkage is expected to be the clinical effect of angiogenesis inhibitors, some of the challenges and potential solutions for clinical trial design are also discussed.
引用
收藏
页码：11 / 16
页数：5
相关论文
共 50 条
  • [31] INVESTIGATIONS ON COPPER CORROSION INHIBITORS.
    Agrawal, O.P.
    Bhatnagar, I.K.
    Kumar, Virendra
    Key Engineering Materials, 1987, 20-28 (pt 1-4)
  • [32] Thiazolidinediones as novel farnesyltransferase inhibitors.
    Ayral-Kaloustian, S
    Birnberg, GH
    Cheung, K
    Epstein, JW
    MacEwan, G
    Salaski, E
    Hollander, I
    Kim, SC
    Chen, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U653 - U653
  • [33] Structural aspects of coagulation inhibitors.
    Stubbs, MT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 113 - MEDI
  • [34] Molecular modeling of HIV inhibitors.
    Sinclair, K
    Parish, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U170 - U170
  • [35] Copper corrosion inhibitors. A review
    Antonijevic, M. M.
    Petrovic, M. B.
    INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE, 2008, 3 (01): : 1 - 28
  • [36] Design and mechanism of enzyme inhibitors.
    Silverman, RB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U159 - U159
  • [37] Synthesis of trypanothione reductase inhibitors.
    Spalding, MD
    Alberg, DG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U413 - U413
  • [38] Metal casings as rust inhibitors.
    不详
    ZEITSCHRIFT DES VEREINES DEUTSCHER INGENIEURE, 1921, 65 : 555 - 555
  • [39] Orally active γ-secretase inhibitors.
    Olson, RE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U941 - U941
  • [40] Protein kinase C inhibitors.
    Swannie H.C.
    Kaye S.B.
    Current Oncology Reports, 2002, 4 (1) : 37 - 46
12345